Skip to content

Author

Chris Pickford

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Preclinical Characterization of ADCT-241, an Exatecan-Based Antibody-Drug Conjugate Against PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Prostate-specific membrane antigen (PSMA) is a type II transmembrane glycoprotein with elevated expression in primary and metastatic prostate cancer (PCa) compared with normal prostate tissues; with low levels in renal proximal tubules, small intestine, and the brain. PSMA is a clinically validated target and is associ...

Asma Jabeen, B. Leatherdale, Rebecca Martin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.